These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


289 related items for PubMed ID: 7966037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S, Falbo A, Orio F, Manguso F, Russo T, Tolino A, Annamaria C, Dale B, Zullo F.
    Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
    [Abstract] [Full Text] [Related]

  • 6. Proper selection of patients for intermediate-dose pure follicle stimulating hormone.
    Kim JH, Richards CJ, Seibel MM.
    J Reprod Med; 1994 Jan; 39(1):1-5. PubMed ID: 8169907
    [Abstract] [Full Text] [Related]

  • 7. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
    Orvieto R, Homburg R.
    Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384
    [Abstract] [Full Text] [Related]

  • 8. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A.
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [Abstract] [Full Text] [Related]

  • 9. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL, Farhi J, Homburg R, Jacobs HS.
    Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
    [Abstract] [Full Text] [Related]

  • 10. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR, Yergök YZ, Ertekin A, Küçük T, Müngen E, Tütüncü L.
    J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
    [Abstract] [Full Text] [Related]

  • 11. Advances in induction of ovulation.
    Franks S, Gilling-Smith C.
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):136-40. PubMed ID: 8193252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S, Paradisi R, Fabbri R, Porcu E, Orsini LF, Flamigni C.
    Int J Fertil; 1987 Apr; 32(1):66-70. PubMed ID: 2880819
    [Abstract] [Full Text] [Related]

  • 14. [Contribution of pure FSH in ovulation induction excluding fertilization in vitro].
    Buvat J, Buvat-Herbaut M, Marcolin G, Verbecq P.
    Rev Fr Gynecol Obstet; 1991 Feb 15; 86(2):91-6. PubMed ID: 1905833
    [Abstract] [Full Text] [Related]

  • 15. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L, Puca F, Emidi E, Manicuti C, Madrigale A, Piccione E.
    Arch Gynecol Obstet; 2012 Nov 15; 286(5):1291-7. PubMed ID: 22729136
    [Abstract] [Full Text] [Related]

  • 16. Ovulation induction in normogonadotropic anovulation (PCOS).
    van Santbrink EJ, Fauser BC.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun 15; 20(2):261-70. PubMed ID: 16772156
    [Abstract] [Full Text] [Related]

  • 17. [Purified FSH in small doses. Is this not the best current treatment of polycystic ovaries resistant to clomid? 73 cycles].
    Drapier-Faure E.
    J Gynecol Obstet Biol Reprod (Paris); 1991 Jun 15; 20(5):651-5. PubMed ID: 1955660
    [Abstract] [Full Text] [Related]

  • 18. Induction of ovulation in the patient with polycystic ovarian disease.
    Blankstein J, Quigley MM.
    Endocrinol Metab Clin North Am; 1988 Dec 15; 17(4):733-49. PubMed ID: 3143566
    [Abstract] [Full Text] [Related]

  • 19. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
    Mitwally MF, Casper RF.
    J Soc Gynecol Investig; 2004 Sep 15; 11(6):406-15. PubMed ID: 15350255
    [Abstract] [Full Text] [Related]

  • 20. Daily or alternate-day FSH therapy in patients with polycystic ovarian disease resistant to clomiphene citrate treatment.
    McFaul PB, Traub AI, Sheridan B, Leslie H.
    Int J Fertil; 1989 Sep 15; 34(3):194-8. PubMed ID: 2567714
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.